R&D Navigating development in a complex molecule world For decades, the pharmaceutical industry has relied on accelerated development and manufacturing timelines to bring new therapies to patients quickly.
R&D Saudi pharma’s rise as a global CDMO destination: Investment... Saudi Arabia is steadily establishing itself as a competitive worldwide destination for contract development and manufacturing.
Digital Sponsored Future proofing production: Implementing AI in pharmaceutica... Read Zühlke’s new white paper, ‘Future Proof Production: Implementing AI in pharmaceutical manufacturing’ today.
Market Access How manufacturing keeps pace with innovation in cell and gen... Cell and gene therapies are one of the most fast-moving and paradigm-shifting areas in pharmaceutical development today, bringing curative treatments to patients for the first time for cert
R&D Why Ireland has emerged as Europe’s biopharma hotspot Ireland is attracting major investment from the largest pharma companies in the world.
Partner Content Partner Content Calling all Pharma Cleanroom Experts… Join us in London Calling all Pharma Cleanroom Experts
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.